Company: CMND
Filing Date: 2025-09-19
Form Type: F-1
Source: 0001213900-25-089545
Chunk: 54

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-19
Form: F-1
Chunk 54
---
 with this Registration Statement on Form F-1, including the power and authority to sign for
us in our names in the capacities indicated below any and all further amendments to this registration statement and any other registration
statement filed pursuant to the provisions of Rule 462 under the Securities Act.

Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature                
 /s/ Dr. Adi Zuloff-Shani |     | Title                                       
 Chief Executive Officer                     |     | Date      
 September 
 19, 2025  |
|:-------------------------|:----|:--------------------------------------------|:----|:----------|
| Dr. Adi Zuloff-Shani     |     | -Principal Executive Officer                |     |           |
| /s/ Alan Rootenberg      |     | Chief Financial Officer                     |     | September 
 19, 2025  |
| Alan Rootenberg          |     | -Principal Financial and Accounting Officer |     |           |
| /s/ Amitay Weiss         |     | Chairman of the Board of Directors          |     | September 
 19, 2025  |
| Amitay Weiss             |     |                                             |     |           |
| /s/ Oz Adler             |     | Director                                    |     | September 
 19, 2025  |
| Oz Adler                 |     |                                             |     |           |
| /s/ Yehonatan Shachar    |     | Director                                    |     | September 
 19, 2025  |
| Yehonatan Shachar        |     |                                             |     |           |
| /s/ Asaf Itzhaik         |     | Director                                    |     | September 
 19, 2025  |
| Asaf Itzhaik             |     |                                             |     |           |
| /s/ Hila Kiron-Revach    |     | Director                                    |     | September 
 19, 2025  |
| Hila Kiron-Revach        |     |                                             |     |           |

<div align='center'>II-7

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Clearmind Medicine
Inc., has signed this Registration Statement on this 19